# A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

> **NCT00432380** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 375 (actual)

## Conditions studied

- Infections, Rotavirus
- Rotavirus Vaccines

## Interventions

- **BIOLOGICAL:** Rotarix™
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00432380
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03-09
- **Primary completion:** 2007-09-04
- **Final completion:** 2007-09-04
- **Target enrollment:** 375 (ACTUAL)
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432380, "A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00432380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*